Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Last updated: January 6, 2025
Sponsor: University of Pittsburgh
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mycosis Fungoides

Atopic Dermatitis

Sezary Syndrome

Treatment

Blood draw, skin biopsy or urine collection

Clinical Study ID

NCT00177268
STUDY19010322
  • Ages > 18
  • All Genders

Study Summary

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 or older

  • able and willing to provide informed consent

  • diagnosed with CTCL

  • diagnosed with either atopic dermatitis or eczema

Exclusion

Exclusion Criteria:

  • Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Blood draw, skin biopsy or urine collection
Phase:
Study Start date:
October 01, 2004
Estimated Completion Date:
January 31, 2032

Study Description

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor:

  • immunologic assays/flow cytometry

  • tumor progression/regression

  • genomic studies

  • proteomic studies

  • others germane to the advancement of CTCL treatment

Connect with a study center

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania 15213
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.